editorial Archives | Oncotarget

Oncotarget News

Persistence Barcodes: Reducing Bias in Radiological Analysis

November 20, 2024

Persistence barcodes emerge as a promising tool in radiological analysis, offering a novel approach to reduce bias and uncover hidden patterns in medical imaging.”BUFFALO, NY - November 20, 2024 – A... read more

Oncotarget

Reducing Bias in Radiology with Topological Data Analysis

November 18, 2024

By providing a more comprehensive, robust, and interpretable framework for analyzing medical imaging data, TDA has the potential to enhance the accuracy and fairness of radiological assessments.”BUFFALO, NY - November... read more

Oncotarget

Navigating Bias in AI-Driven Cancer Detection

November 11, 2024

As we eagerly adopt Al models, we need to take a moment to think about the potential biases that they may contain.”BUFFALO, NY - November 11, 2024 – A new editorial... read more

Oncotarget

How Blood Cancer Cells Rewire to Evade Drug Treatment

October 23, 2024

drugs that target individual signalling pathways in AML often fail to stop proliferation malignant growth, due to the wide variety, redundancy and cross talk between multiple pathways regulating and differentiation.”... read more

Oncotarget

TP53 Mutated AML: Transplant or No Transplant

October 11, 2024

In summary, this study reported improved survival when allo-HTC was performed in CR1 versus after later lines of therapy.”BUFFALO, NY- October 11, 2024 – A new editorial was published in... read more

Oncotarget

Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy

October 7, 2024

While the ACDC-RP trial adds to the litany of negative trials in this disease space, there are key takeaways from this trial that can inform future clinical trial design.”BUFFALO,... read more

Oncotarget

The Role of Artificial Intelligence in Advancing Intratumoral Immunotherapy

September 19, 2024

We explore how integrating these technologies could revolutionize personalized oncology.”BUFFALO, NY- September 19, 2024 – A new editorial was published in Oncotarget's Volume 15 on September 17, 2024, entitled, “The... read more

Oncotarget

Targeting CD47/SIRPα “Do Not Eat Me” Axis: Advances and Challenges in Cancer Therapy

September 11, 2024

Numerous phagocytosis checkpoints and ‘do not eat me’ signals (i.e., CD47, CD24, MHC-I, PD-L1, STC1, and GD2) have recently been recognized as potential therapeutic targets.”BUFFALO, NY- September 11,... read more

Oncotarget

Next-Gen Vaccines Offer New Hope Against Glioblastoma

September 9, 2024

Vaccines have been considered a promising approach for GBM for many years.”BUFFALO, NY- September 9, 2024 – A new editorial was published in Oncotarget's Volume 15 on August 5, 2024,... read more

Oncotarget

Generative AI in Cancer Imaging: Revolutionizing Detection & Diagnosis

September 6, 2024

This editorial explores its impact on expanding datasets, improving image quality, and enabling predictive oncology.”BUFFALO, NY- September 6, 2024 – A new editorial was published in Oncotarget's Volume 15 on... read more